Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

708
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
708
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

1.9K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.9K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

3.2K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.2K
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

459
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
459
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Diagnostic Potential of Combined Skin Morphometric Analysis and Salivary Alpha-Synuclein Oligomers in Parkinson's Disease.

Cells·2026
Same author

Anxiety and depression as prodromes of Parkinson's disease: prospective findings from the Moli-sani study.

Journal of neurology·2026
Same author

In Memoriam of Prof. Mark Hallett (1943-2025).

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Early functional network alterations predict motor and cognitive decline in parkinson's disease.

Scientific reports·2025
Same author

Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia?

Journal of the neurological sciences·2025
Same author

The impact of diet on Parkinson's disease risk: A data-driven analysis in a large Italian case-control population.

Journal of Parkinson's disease·2025
Same journal

Glutamate-Glutamine metabolism and transport, implications in Parkinson's disease.

International review of neurobiology·2026
Same journal

Redox bioenergetics of neuronal senescence in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Neurovascular coupling and energy substrate delivery in Alzheimer's disease.

International review of neurobiology·2026
Same journal

From metals to mitochondria: Linking trace elements to energy crisis in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Invisible threats of microplastics induced toxicity: Oxidative and inflammatory pathways in the CNS and retina.

International review of neurobiology·2026
Same journal

Starved synapses: Gut microbiome dysbiosis and its role in Alzheimer's glucose impairment.

International review of neurobiology·2026
查看所有相关文章

相关实验视频

Updated: Jul 22, 2025

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.4K

肉毒毒素究竟是如何起作用的?

Daniele Belvisi1, Giorgio Leodori1, Matteo Costanzo2

  • 1Department of Human Neurosciences, Sapienza, University of Rome, Viale dell' Università 30, Rome, Italy; IRCCS Neuromed, via Atinense 18, Pozzilli, IS, Italy.

International review of neurobiology
|July 23, 2023
PubMed
概括
此摘要是机器生成的。

毒素 (BoNT) 通过影响肌肉神经来有效治疗 dystonia. 新出现的证据表明,其治疗益处可能源于调节感官反和神经通路,而不仅仅是直接的肌肉作用.

关键词:
肉毒毒素是一种毒素.中枢神经系统中枢神经系统迪斯托尼亚 (Dystonia) 是一种疾病.作用机制 作用机制肌肉的线是肌肉的线.神经肌肉结节的神经肌肉结节

更多相关视频

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.0K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.7K

相关实验视频

Last Updated: Jul 22, 2025

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.4K
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.0K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.7K

科学领域:

  • 神经学 神经学
  • 药理学 药理学是指药理学的学科.
  • 神经科学是一个神经科学.

背景情况:

  • 三十年来,肉毒毒素 (BoNT) 是一种被公认的治疗神经系统疾病的疗法,如 dystonia.
  • 底层的 BoNT 在 dystonia 的有效性精确的机制仍然不完全阐明.
  • 虽然BoNT的主要作用在神经肌肉结处,但其在调节外围感官反中的作用越来越被认可.

研究的目的:

  • 审查和综合目前关于毒素在 dystonia 治疗中的潜在作用机制的研究.
  • 探索证据支持BoNT在 dystonia 中对外周感官反的调制.
  • 讨论BoNT的中心效应的含义,在人类中可能由 afferent输入调制介导.

主要方法:

  • 审查现有的科学文献和研究证据.
  • 对调查肉毒毒素对神经肌肉结节和感官通路的影响的研究分析.
  • 对动物模型和人类研究的检查,涉及毒素在 dystonia 的作用机制.

主要成果:

  • 毒素 (BoNT) 主要作用于神经肌肉结节.
  • 有证据表明,BoNT在 dystonia 的治疗效果涉及调节肌肉的感觉反.
  • 人类研究表明,BoNT的中心效应可能与与轴突运输不同的附带输入调制有关.

结论:

  • 毒素 (BoNT) 在 dystonia 的治疗作用是多方面的,延伸到超出神经肌肉结.
  • 调节周围感官反是促进BoNT在 dystonia 疗效的一个关键机制.
  • 了解这些机制对于优化基于BoNT的 dystonia 治疗至关重要.